Just to clarify, you talked about advance market commitment. We had Bioniche before us in Ottawa, and my recollection here is that they were asking for a $15 million program or something whereby the new vaccine, that I think was developed in concert with VIDO...that some money would be allocated to producers. Producers would then buy the product and apply it to their cattle.
Is that different from what you're talking about, in terms of this advance market commitment? It was in response to a question from Mr. Stanton.